McCracken et al., 2012 - Google Patents
A new in vivo model for luteolysis using systemic pulsatile infusions of PGF2αMcCracken et al., 2012
- Document ID
- 14271217913370321816
- Author
- McCracken J
- Custer E
- Schreiber D
- Tsang P
- Keator C
- Arosh J
- Publication year
- Publication venue
- Prostaglandins & Other Lipid Mediators
External Links
Snippet
A new in vivo model for studying luteolysis was developed in sheep to provide a convenient method for collecting corpora lutea for molecular, biochemical, and histological analysis during a procedure that mimics natural luteolysis. It was found that the infusion of …
- 230000029860 luteolysis 0 title abstract description 80
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bridges et al. | Determination of the appropriate delivery of prostaglandin F2α in the five-day CO-Synch+ controlled intravaginal drug release protocol in suckled beef cows | |
| McCracken et al. | A new in vivo model for luteolysis using systemic pulsatile infusions of PGF2α | |
| Brown et al. | Serum and urinary hormones during pregnancy and the peri‐and postpartum period in an Asian elephant (Elephas, maximus) | |
| Vanderwall et al. | Concentrations of oxytocin in the intercavernous sinus of mares during luteolysis: temporal relationship with concentrations of 13, 14-dihydro-15-keto-prostaglandin F2α | |
| Carbonaro et al. | Behavioral and physiological responses of dairy goats to isolation | |
| Sanchez-Franco et al. | Influence of sex phase of the menstrual cycle on thyrotropin (TSH) response to thyrotropin-releasing hormone (TRH) | |
| Gorewit et al. | Current concepts on the role of oxytocin in milk ejection | |
| Kuhl et al. | The PGF2α agonists luprostiol and d-cloprostenol reliably induce luteolysis in luteal phase mares without evoking clinical side effects or a stress response | |
| Nicholson et al. | The inhibitory effect of intestinal infusions of unsaturated long-chain fatty acids on forestomach motility of sheep | |
| Rampacek et al. | Comparison of physiological indicators of chronic stress in confined and nonconfined gilts | |
| McCann et al. | Insulin and glucose responses to glucose injection in fed and fasted obese and lean sheep | |
| Viana et al. | Efficacy of induction of luteolysis in superovulated cows is dependent on time of prostaglandin F2alpha analog treatment: effects on plasma progesterone and luteinizing hormone profiles | |
| Ginther et al. | The transition between preluteolysis and luteolysis in cattle | |
| Irvine et al. | Effectiveness of a two‐dose regimen of prostaglandin administration in inducing luteolysis without adverse side effects in mares | |
| Gilbert et al. | Pulsatile release of oxytocin into the circulation of the ewe during oestrus, mating and the early luteal phase | |
| Gkeiss Jr | Differential reactivity of the myoendometrial and placental vasculatures: Vasodilatation | |
| Carluccio et al. | Luteal function in jennies following PGF2α treatment 3 days after ovulation | |
| Romano et al. | Onset of luteolytic action of exogenous prostaglandinF-2α during estrous cycle in goats | |
| Wijma et al. | Circulating progesterone dynamics after intravaginal instillation of prostaglandin-F2α to lactating dairy cows | |
| Pulley et al. | Five-day resynchronization programs in dairy cows including presynchronization and progesterone at two stages following artificial insemination | |
| Ginther et al. | Hormone concentrations temporally associated with contralateral and ipsilateral relationships between the CL and preovulatory follicle during the third follicular wave in heifers | |
| Sawin | THEORIES OF CAUSATION OF GRAVES'DISEASE: A Historical Perspective | |
| Challis et al. | Production of prostaglandin Fα in ewes following luteal regression induced with a prostaglandin analogue, Estrumate (cloprostenol; ICI 80996) | |
| Ginther et al. | Stimulation of pulses of 13, 14-dihydro-15-keto-PGF2α (PGFM) with estradiol-17β and changes in circulating progesterone concentrations within a PGFM pulse in heifers | |
| Richardson et al. | The effects of glucagon, secretin, pancreozymin and pentagastrin on the hepatic arterial vascular bed of the dog |